8
Oct
2024

DavosPharma

Exhibitor at CPHI Milan 2024 stand 4B57, API
About Us

DavosPharma, a leading provider of discovery, chemistry and formulation services, offers solutions to both emerging biotech and established multinationals during drug development with supporting developmental, analytics, stability and regulatory documentation. DavosPharma has fifty years of custom manufacturing experience, forming global strategic alliances with carefully vetted, best-in-class, cGMP custom manufacturers.

  • US
  • 2015
    On CPHI since
  • 1 - 24
    Employees
Company types
CMO/CDMO
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4B57, API

Products Featured at CPHI Milan 2024

  • API Synthesis

    Product API Synthesis

    DavosPharma offers a wide range of services which includes API Synthesis. They offer Small Molecule, Process Development, Impurity Profiles, Analytical Development, Familiarization Synthesis. Contact us for more information.
  • Biologics services

    Product Biologics services

    DavosPharma offers a wide range of services which includes Biologics services. They offer Peptide and Protein Expression (multiple expression systems), Virus Production, mAb Development and Production, Vaccines and Virus-like Particles, Cell-based Therapies. Contact us for more information.
  • Carcinogenesis

    Product Carcinogenesis

    DavosPharma offers a wide range of services which includes Carcinogenesis. Contact us for more information.
  • Chemical Technologies

    Product Chemical Technologies

    DavosPharma offers a wide range of services which includes Chemical Technologies. They offer High Purity Chemicals (>99.5%), Chromatography, Kinetic Resolutions, Asymmetric Synthesis, Heterocyclic Commpounds. Contact us for more information.
  • Chronic & Inhalation toxicology

    Product Chronic & Inhalation toxicology

    DavosPharma offers a wide range of services which includes Chronic & Inhalation toxicology. Contact us for more information.